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ORIGINAL STUDIES
Responsiveness and Construct Validity of a Symptom Scale for
Acute Otitis Media
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Background: Because resolution of symptoms is a primary goal of antimi-
crobial therapy in children with acute otitis media (AOM), measurement of
symptoms in studies of antimicrobial effectiveness in such children is
important. We have developed a scale for measuring symptoms of AOM in
young children (AOM-SOS), and we present data on its construct validity
and responsiveness.
Methods: We followed children 3 months to 3 years of age with AOM, who
were receiving antimicrobial treatment, using the AOM-SOS scale. The scale
was administered at the enrollment visit, as a twice-a-day diary measure, and
at the follow-up visit (days 5–7). To evaluate construct validity, we examined
the correlation, at entry, between AOM-SOS scores and scores on other
measures of pain and functional status. To evaluate the scale’s responsive-
ness, we examined the change in scale scores from entry to follow-up. We
also examined the levels of agreement between the scale scores and overall
assessments of the children by parents.
Results: We enrolled 70 children (mean age 12.5 months) of whom 57 returned
for follow-up. The magnitude of the correlations between the AOM-SOS scale
scores and other measures of pain and functional status ranged from 0.56 to 0.84.
The responsiveness of the AOM-SOS, as measured by the standardized response
mean was 1.20.
Conclusions: These data support the validity and responsiveness of the
AOM-SOS; the scale seems to measure effectively both pain and overall
functional status in young children with AOM. Changes in score over the
first few days of illness were substantial and generally matched the assess-
ments both of parents and of clinicians. The AOM-SOS promises to be useful
as an outcome measure in clinical studies of AOM.
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(Pediatr Infect Dis J 2009;28: 9–12)
A growing body of evidence suggests that using surrogate out-comes as sole measures of efficacy in clinical trials is not
sufficient.1 Surrogate outcomes refer to test results that are used in
place of clinical outcomes in trials of efficacy. Although often easy
to measure, surrogate outcomes frequently lack direct clinical rele-
vance.2
In clinical trials of antimicrobial efficacy in children with
acute otitis media (AOM), eradication of bacteria from middle ear
fluid has frequently served as the sole outcome measure.3 However,
because resolution of symptoms is a primary goal of antimicrobial
therapy, and because bacteriologic outcomes do not accurately
predict symptomatic outcomes,2,4,5 measurement of symptoms
should logically be part of all efficacy trials. That the measurement
of symptoms has often not been undertaken has been attributable in
part to the lack of a properly validated outcome measure.
We have developed an outcome instrument that measures
symptoms of AOM in young children: the acute otitis media severity
of symptom scale (AOM-SOS). In developing the instrument we
used parent questionnaire, review of the literature, and consultation
with experts. In a preliminary study, we showed that AOM-SOS
scores correlated well with otoscopic diagnosis (ie, either AOM,
otitis media with effusion, or normal middle ear status), and that
scores changed as expected with changes in clinical status.6
In the present study, we used a revised version of the
AOM-SOS, which differed from the version used in our preliminary
study in that we separated the single question concerning irritability
(ie, fussiness or increased crying) into separate components, namely,
irritability, and increased crying. In addition, instead of using the
recorded temperature, we asked parents to estimate the degree of
fever (none, a little, or a lot). We evaluated: (1) whether the
AOM-SOS as revised was adequately responsive for use as a clinical
end point in AOM trials; (2) whether AOM-SOS scores correlated
with other measures of pain and quality of life; (3) whether changes
in AOM-SOS scores correlated with assessments by parents; and (4)
whether parents had difficulty in interpreting either the instructions
for using the instrument or the instrument’s contents.
METHODS
We enrolled consecutive children aged 3 months to 3 years
presenting with AOM to a general ambulatory pediatric clinic at
Children’s Hospital of Pittsburgh between November 2005 and May
2006. Our criteria for diagnosing AOM consisted of (1) the presence
of bulging or distinct erythema of the tympanic membrane (TM);
and (2) middle ear effusion, as evidenced either by the presence of
at least 2 of 3 TM findings, namely, opacity, yellow or white
discoloration, or decreased mobility, or by the presence of air-fluid
interfaces. We excluded children who were asymptomatic or who
had tympanostomy tubes in place, otorrhea, or a TM perforation, as
well as children about to undergo diagnostic tympanocentesis. All
children were treated with antimicrobials chosen by their respective
primary-care providers. The study-team otoscopists (A.H., N.S.,
L.Z.) were not blinded to children’s symptoms. The investigators
had extensive experience in conducting AOM-related clinical re-
search. There was good interobserver agreement between the 3
otoscopists;  values derived from diagnoses registered in a 50-ear
video-otoscopic test ranged from 0.78 to 0.81.
From the date of enrollment (day 1) we followed children
with AOM for 5–7 days. At both the enrollment visit and the
follow-up visit (days 5–7), we interviewed parents regarding their
child’s symptoms by reading verbatim the questions on the AOM-
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SOS. We then performed otoscopic examination and asked parents
to complete 3 reference measures:
• A 10-point pain scale in which parents rated the severity of their
child’s pain from 0 (“no pain”) to 10 (“worst possible pain”);
• The Pediatric Postoperative Pain Measure for Parents, in which
parents assessed the presence or absence of 15 nonverbal pain-
related behaviors. Higher scores indicate greater degrees of pain.
This scale was developed for use in children 1–15 years of age,7
and seemed appropriate for use in this study; and
• The Functional Status Questionnaire,8 a 14-item scale that mea-
sures overall health status in children 0–16 years of age. The
questionnaire asks parents about the presence or absence of key
behaviors over the preceding 2-week period. Higher scores indi-
cate more favorable status. For the present study, we modified the
questionnaire to ask only about the preceding day while leaving
unchanged the wording, sequence, and number of questions.
During the interval between the enrollment (day 1) and the
follow-up visit, we asked parents to complete the AOM-SOS twice
daily, and also to rate whether, on the morning of day 2, compared
with the time of enrollment, their child was “a lot better,” “a bit
better,” “the same,” “a bit worse,” or “a lot worse.”
To evaluate how parents interpreted questions on the AOM-
SOS, we conducted face-to-face semi-structured interviews with 10
parents at the follow-up visit. In these interviews, we questioned
parents regarding any difficulties in understanding the instructions,
in understanding the qualifier “more than usual,” in understanding
the meaning of each symptom, or in completing diaries. We asked
the parents to elaborate on their answers and we recorded their
responses verbatim.
To estimate cross-sectional construct validity, we examined
the correlation between AOM-SOS scores and scores on reference
measures at the enrollment visit. To determine longitudinal construct
validity, we compared changes in AOM-SOS scores (from day 1 to
days 5–7) with changes in reference measure scores. We had
hypothesized, a priori, a correlation of 0.5 between changes in
AOM-SOS scores and changes in scores on measures of pain and a
correlation of 0.6 between changes in AOM-SOS scores and
changes in scores on the functional status measure.
To evaluate responsiveness–the ability of the instrument’s
scores to change in conjunction with changes in clinical status–we
examined the change in AOM-SOS scores from enrollment to the
follow-up visit. Generally, an instrument is considered responsive
when the mean change in scores is large relative to the scores’
variability. We calculated the standardized response mean (SRM) by
dividing the magnitude of the mean change in score by the standard
deviation of the change. An SRM 0.5 usually indicates good
responsiveness.9–11
All questions on the AOM-SOS, with the exception of the
question about ear pain, ask parents about directly observable
behaviors. The question about ear pain, in contrast, asks parents to
interpret and synthesize information from a variety of sources, and
may accordingly be more prone to variability. We therefore explored
the psychometric ramifications of removing this question from the
instrument, and found no appreciable difference in results whether
the ear pain question was or was not included (details are available
from the authors on request). The results presented here are those
obtained with the question excluded.
All analyses were performed using 2-tailed tests, with statis-
tical significance set at P  0.05. We used 2 tests to evaluate
differences in proportions, the t test to test for differences between
mean results, and present Pearson correlation coefficients.
RESULTS
We enrolled 70 children with AOM (mean age, 12.5 months;
range, 3–28 months). Selected demographic and clinical character-
istics of the children are shown in Table 1. All children were
symptomatic (mean AOM-SOS score 6.39). A total of 57 children
returned for their follow-up evaluation; mean time to follow-up was
6.1 days. There were no significant differences in race, gender, or
age between children who returned for follow-up and those who did
not. Parents had little difficulty completing the AOM-SOS at home;
of the 475 questionnaires received, only 8 (1.7%) had any missing
data.
Construct Validity
Table 2 shows the correlations between AOM-SOS scores
and scores on reference measures at the time of enrollment, and the
correlations between changes in AOM-SOS scores from day 1 to
days 5–7 and changes in scores on those reference measures in that
interval. The magnitude of the correlations ranged in the expected
directions from 0.56 to 0.84 and were similar to the values we had
predicted a priori.
Responsiveness
Mean AOM-SOS scores at the baseline and at follow-up
visits (days 5–7) were 6.39 and 1.34, respectively. Day-to-day
changes in AOM-SOS scores are shown in Figure 1. The SRM was
1.20. Seven children had an AOM-SOS score that was unchanged or
higher at the follow-up compared with the baseline visit. Of these, 2
had developed an intercurrent illness (1 with exudative pharyngitis
and 1 with viral upper respiratory tract infection) and 2 had persis-
tently bulging tympanic membranes.
Parental Assessment
As shown in Table 3, we noted good overall agreement
between change in AOM-SOS scores and parents’ assessment of
change from day 1 to day 2. Among the 19 children who were
TABLE 1. Distribution of Children According to
Selected Demographic and Clinical Characteristics
Characteristic No.(%) Children(n  70)
Age at entry, months
3–6 12 (17)
7–12 29 (41)
13–18 19 (27)
19–24 7 (10)
25–30 3 (4)
Gender
Male 39 (56)
Female 31 (44)
Race
White 22 (31)
African American 44 (63)
Other 4 (6)
Maternal education
Less than high school 7 (10)
High school graduate/GED 48 (69)
College graduate 15 (21)
Health insurance
Private 13 (19)
Public 56 (80)
None 1 (1)
Day care (4 h a week)
Yes 27 (39)
No 43 (61)
Current upper respiratory infection
Yes 66 (94)
No 4 (6)
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considered “a bit better” by their parents, AOM-SOS scores de-
creased by a mean of 4.2 points. This can be used as a rough
estimate for the minimal important difference. We are currently
conducting a large study using the AOM-SOS, which will allow us
to more precisely estimate the minimal important difference.
Parents’ Understanding and Use of the
AOM-SOS (Cognitive Debriefing)
None of the 10 parents interviewed reported any difficulties in
understanding either the instructions or the meaning of the word
“usual.” Except for the question on ear pain, all of the items on the
instrument were regarded as “very easy” or “easy” to understand by
9 of the 10 parents; however, 5 of the 10 parents had difficulty with
the ear pain item. In most of these instances, parents reported that
they were unable to determine with certainty whether their child was
experiencing ear pain. Tugging, rubbing, holding, or pulling at the
ear, however, seemed to be well understood by most parents; when
asked to explain the meaning of such behavior, 8 of the 10 parents
associated it with ear pain.
FIGURE 1. Day-to-day change in mean AOM-SOS scores in 70 children with AOM receiving antimicrobial therapy.
TABLE 2. Correlations Between AOM-SOS Scores and
Scores on Reference Measures at Enrollment (Day 1), and
Correlations Between Changes (From Enrollment to
Follow-Up on Day 5–7) in AOM-SOS Scores and Changes
in Reference Measure Scores
Reference
Measure
Correlations
AOM-SOS Scores
and Reference
Measure Scores
(Day 1)
Changes in AOM-SOS Scores
and Changes in Reference
Measure Scores
(Day 1 to Day 5–7)
Pain rating scale 0.56 0.60
Postoperative
pain scale
0.82 0.85
Functional
status scale
0.83 0.84
TABLE 3. Change in AOM-SOS Score from Day 1 to
Day 2 in Relation to Parental Assessment of Change in
Overall Status from Day 1 to Day 2
Change in
AOM-SOS Score
Parental Assessment of Status on Day 2*
A Lot
Worse
A Bit
Worse
The
Same
A Bit
Better
A Lot
Better
9
8 1
6 1
2 3
1 2
0 1 2 1
1 4 3
2 3 2
3 2 2 1
4 5
5 1 5
6 2
7 1 1
8 1
10 1
*Parental assessment was available for only 45 of the 70 children in the study.
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DISCUSSION
In a previous study, we described the development and
preliminary evaluation of a parent-reported symptom instrument for
children with AOM.6 In the present report, we present additional
data on the responsiveness and validity of the AOM-SOS. We have
shown that the day-to-day responsiveness of the AOM-SOS sug-
gests it as a potentially useful tool in following the symptom burden
of AOM in clinical trials. Further, we have shown that the instru-
ment correlates well with results of other measures of pain and
functional status. Accordingly, mean change in AOM-SOS scores
from baseline to follow-up could be used as one measure of
improvement or deterioration. Although variability exists in how
individual children respond to AOM and in how parents perceive
and report their child’s AOM symptoms, measurement error would
be lessened because each child acts as his or her own control.
Importantly, our results do not suggest using the AOM-SOS
score alone at any stage of AOM for determining the severity of the
illness or for managing individual cases. Rather, we propose 2 ways
to use AOM-SOS scores. In the first approach, time to achievement
of a specified score would be compared between treatment groups.
In the second approach, mean change in score would be compared
between treatment groups at one or more designated time points.
Here, the minimally important difference—the change in score that
parents endorse as important—could be used to interpret re-
sults.12–14
We have slightly modified the AOM-SOS based on findings
of this study. First, we removed the question about ear pain from the
instrument in response to some parents’ difficulty in interpreting this
item and because removal of this item did not seem to affect the
overall performance of the instrument. Second, in an effort to reduce
variability in responses regarding time frame being assessed, we
have decided to incorporate the phrase “over the past 12 hours” in
each question (version 3.0, Table 4).
A limitation of the present study is that the AOM-SOS was
administered in 2 ways: by direct questioning by investigators at
enrollment and follow-up visits and by parents recording responses
in a written diary at all intermediate measurement points. Some
variability may have thereby been introduced; direct questioning
seemed to have resulted in slightly higher symptom scores. Using a
single method of administration, either interview or self-report,
might therefore be preferable in future studies.
In summary, this study provides additional data on the valid-
ity and responsiveness of the AOM-SOS, and further supports its use
as a measure of outcome in clinical studies of AOM in young
children.
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TABLE 4. AOM-SOS (Version 3.0)*
We are interested in finding out how your child has been doing. For
each question, please place a check mark in the box corresponding to
your child’s symptoms. Please answer all questions.
No A Little A Lot
Over the past 12 h, has your child been
tugging, rubbing, or holding the ear(s) more
than usual?
  
Over the past 12 h, has your child been crying
more than usual?
  
Over the past 12 h, has your child been more
irritable or fussy than usual?
  
Over the past 12 h, has your child been
having more difficulty sleeping than usual?
  
Over the past 12 h, has your child been less
playful or active than usual?
  
Over the past 12 h, has your child been eating
less than usual?
  
Over the past 12 h, has your child been
having fever or feeling warm to touch?
  
*Reprinted with permission. © 2008, University of Pittsburgh. All Rights Reserved.
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